100 results
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
10 Jun 24
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
8:45am
-profit kidney care company. She served on the Quality, Safety & Patient Experience and the Government & Compensation Executive & Strategy committees … ,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
7 Jun 24
SeaStar Medical Announces 25-for-1 Reverse Stock Split
5:25pm
and compliance with NASDAQ listing requirements. Words such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
14 May 24
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
4:05pm
annually,” said Eric Schlorff, SeaStar Medical CEO. “Our launch strategy entails qualifying five prominent children’s hospitals as the first to offer … for a clinical trial to evaluate the SCD-ADULT as a bridging strategy to left ventricular assist device implantation in patients with chronic heart failure
8-K
EX-99.1
xbqj1j
17 Apr 24
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
4:01pm
8-K/A
EX-99.1
juhd8x
27 Mar 24
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
5:23pm
8-K
wbgrjf4 o7jcw6xhx
27 Mar 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8:35am
8-K
EX-99.1
4ywqeqe8lzn tl
27 Mar 24
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
8:32am
424B3
gcoizeuqzin 3jof5
5 Mar 24
Prospectus supplement
5:08pm
424B3
9diw7qt5flu529516d
5 Mar 24
Prospectus supplement
5:06pm
424B3
2jq7cwppgyz0nne184lg
5 Mar 24
Prospectus supplement
5:04pm
424B3
4ihts
5 Mar 24
Prospectus supplement
4:59pm
424B3
fov5hdy aq
5 Mar 24
Prospectus supplement
4:56pm
8-K
EX-99.1
5mlak8d84rad
22 Feb 24
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
8:00am
8-K
EX-99.1
enpq8ft
30 Jan 24
SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market
9:18am
8-K
EX-99.1
570p4we 14vk8o
11 Jan 24
SeaStar Medical Appoints David A. Green as Chief Financial Officer
4:10pm